AR045911A1 - Formulaciones auto-emulsionables y formulaciones auto-microemulsionables para la administracion oral de taxoides - Google Patents
Formulaciones auto-emulsionables y formulaciones auto-microemulsionables para la administracion oral de taxoidesInfo
- Publication number
- AR045911A1 AR045911A1 ARP040102492A ARP040102492A AR045911A1 AR 045911 A1 AR045911 A1 AR 045911A1 AR P040102492 A ARP040102492 A AR P040102492A AR P040102492 A ARP040102492 A AR P040102492A AR 045911 A1 AR045911 A1 AR 045911A1
- Authority
- AR
- Argentina
- Prior art keywords
- self
- formulations
- oral administration
- taxoids
- microemulsionable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dispersion Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Formulaciones auto-emulsionables y formulaciones auto-microemulsionables para la administración oral de taxoides. Nuevas formulaciones de taxoides para administración oral. Reivindicación 1: Una formulación auto-microemulsionable para la administración oral de taxoides, que comprende al menos un taxoide, al menos un co-tensioactivo, al menos un aceite y un tensioactivo (Cremophor EL®). Reivindicación 11: Una formulación auto-microemulsionable según las reivindicaciones 1 a 10, donde la formulación comprende 60 % de Crempohor EL, 20 % de Imwitor 888 y 20 % de Miglycol 812N (porcentaje en peso).
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03291798A EP1498143A1 (en) | 2003-07-18 | 2003-07-18 | Self-emulsifying and self-microemulsifying formulations for the oral administration of taxoids |
Publications (1)
Publication Number | Publication Date |
---|---|
AR045911A1 true AR045911A1 (es) | 2005-11-16 |
Family
ID=33462261
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP040102492A AR045911A1 (es) | 2003-07-18 | 2004-07-15 | Formulaciones auto-emulsionables y formulaciones auto-microemulsionables para la administracion oral de taxoides |
Country Status (17)
Country | Link |
---|---|
US (2) | US20050025792A1 (es) |
EP (2) | EP1498143A1 (es) |
JP (1) | JP2009513557A (es) |
KR (1) | KR20060052834A (es) |
CN (1) | CN100566758C (es) |
AR (1) | AR045911A1 (es) |
AT (1) | ATE405293T1 (es) |
AU (1) | AU2004262495B2 (es) |
BR (1) | BRPI0412740A (es) |
CA (1) | CA2532566A1 (es) |
DE (1) | DE602004015994D1 (es) |
HK (1) | HK1089951A1 (es) |
IL (1) | IL173112A0 (es) |
MX (1) | MXPA06000633A (es) |
MY (1) | MY139106A (es) |
TW (1) | TWI337870B (es) |
WO (1) | WO2005014048A1 (es) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5250258B2 (ja) * | 2005-04-20 | 2013-07-31 | 中外製薬株式会社 | 自己乳化型製剤処方の設計方法 |
DK1767545T3 (da) | 2005-09-22 | 2010-03-15 | Biocompatibles Uk Ltd | GLP-1 (Glucagon-lignende peptid-1)-fusionspolypeptider med forøget peptidaseresistens |
FR2922107B1 (fr) * | 2007-10-10 | 2010-02-26 | Aventis Pharma Sa | Nouvelles compositions a base de taxoides |
EP2217063B1 (en) * | 2007-11-08 | 2014-12-17 | Virginia Tech Intellectual Properties, Inc. | Thiolated paclitaxels for reaction with gold nanoparticles as drug delivery agents |
CN102228431A (zh) * | 2010-03-16 | 2011-11-02 | 王国强 | 紫杉烷类化合物的自乳化药物组合物 |
CN101829052B (zh) * | 2010-03-16 | 2011-12-14 | 王国强 | 紫杉烷类化合物的自乳化制剂及其制备方法 |
MY167224A (en) | 2010-05-03 | 2018-08-14 | Teikoku Pharma Usa Inc | Non-Aqueous Taxane Pro-Emulsion Formulations and Methods of Making and Using the Same |
JP2013209294A (ja) * | 2010-07-30 | 2013-10-10 | Meiji Seikaファルマ株式会社 | 液状医薬組成物 |
GB2488788B (en) * | 2011-03-07 | 2013-07-10 | Natco Pharma Ltd | Oral formulation of phenylaminopyrymidine compound with enhanced bioavailability and pharmacological response |
JO3685B1 (ar) | 2012-10-01 | 2020-08-27 | Teikoku Pharma Usa Inc | صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها |
KR101542364B1 (ko) * | 2014-10-31 | 2015-08-07 | 대화제약 주식회사 | 탁산을 포함하는 경구 투여용 약학 조성물 |
TWI715636B (zh) * | 2015-09-30 | 2021-01-11 | 香港商慧源香港創新有限公司 | 口服紫杉烷組合物及方法 |
CN109589305B (zh) * | 2018-12-03 | 2021-03-19 | 昆明积大制药股份有限公司 | 多西他赛-环孢素a共包载自乳化制剂及其制备方法 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5698582A (en) * | 1991-07-08 | 1997-12-16 | Rhone-Poulenc Rorer S.A. | Compositions containing taxane derivatives |
AU679013B2 (en) * | 1992-10-16 | 1997-06-19 | Ibah, Inc. | Convertible microemulsion formulations |
EP0684834A4 (en) * | 1993-02-17 | 1996-09-25 | Smithkline Beecham Corp | MICROEMULSIONS CONTAINING THERAPEUTIC PEPTIDES. |
US6964946B1 (en) * | 1995-10-26 | 2005-11-15 | Baker Norton Pharmaceuticals, Inc. | Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same |
BE1011216A3 (fr) * | 1997-06-13 | 1999-06-01 | Thissen En Abrege L T B Lab | Forme pharmaceutique pour l'administration de paclitaxel, procede de preparation d'une composition de paclitaxel prete a l'emploi et utilisation de cette composition. |
AU756752B2 (en) * | 1998-04-01 | 2003-01-23 | Skyepharma Canada Inc. | Anticancer compositions |
AU4989299A (en) * | 1998-07-14 | 2000-02-07 | Em Industries, Inc. | Microdisperse drug delivery systems |
KR100602725B1 (ko) * | 1998-12-11 | 2006-07-20 | 파마솔루션스, 인코포레이티드 | 물에서 불충분하게 용해되는 약제를 위한 자가-유화용조성물 |
US6267985B1 (en) * | 1999-06-30 | 2001-07-31 | Lipocine Inc. | Clear oil-containing pharmaceutical compositions |
DE19925211B4 (de) * | 1999-06-01 | 2006-01-12 | PBS Pharmaceutical Bulk Substances SA | Kit zur Herstellung einer Formulierung von Paclitaxel |
WO2001028519A1 (de) * | 1999-10-20 | 2001-04-26 | Vesifact Ag | Mikroemulsion-prekonzentrate und mikroemulsionen |
CA2434641A1 (en) * | 2001-01-18 | 2002-08-22 | Pharmacia And Upjohn Company | Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability |
WO2002087563A2 (en) * | 2001-05-01 | 2002-11-07 | Angiotech Pharmaceuticals Inc. | Compositions comprising an anti-microtubule agent and a polypeptide or a polysaccharide and the use thereof for the preparation of a medicament for the treatment of inflammatory conditions |
AU2002357012A1 (en) * | 2001-11-27 | 2003-06-10 | Transform Pharmaceuticals, Inc. | Oral pharmaceutical formulations comprising paclitaxel, derivatives and methods of administration thereof |
EP1498120A1 (en) * | 2003-07-18 | 2005-01-19 | Aventis Pharma S.A. | Semi-solid formulations for the oral administration of taxoids |
-
2003
- 2003-07-18 EP EP03291798A patent/EP1498143A1/en not_active Withdrawn
-
2004
- 2004-07-15 WO PCT/EP2004/008550 patent/WO2005014048A1/en active IP Right Grant
- 2004-07-15 BR BRPI0412740-4A patent/BRPI0412740A/pt not_active IP Right Cessation
- 2004-07-15 AT AT04741330T patent/ATE405293T1/de not_active IP Right Cessation
- 2004-07-15 CA CA002532566A patent/CA2532566A1/en not_active Abandoned
- 2004-07-15 JP JP2006519898A patent/JP2009513557A/ja active Pending
- 2004-07-15 MX MXPA06000633A patent/MXPA06000633A/es active IP Right Grant
- 2004-07-15 CN CNB2004800203392A patent/CN100566758C/zh not_active Expired - Fee Related
- 2004-07-15 KR KR1020067001202A patent/KR20060052834A/ko active Search and Examination
- 2004-07-15 AR ARP040102492A patent/AR045911A1/es not_active Application Discontinuation
- 2004-07-15 EP EP04741330A patent/EP1648517B1/en active Active
- 2004-07-15 DE DE602004015994T patent/DE602004015994D1/de active Active
- 2004-07-15 AU AU2004262495A patent/AU2004262495B2/en not_active Ceased
- 2004-07-16 MY MYPI20042867A patent/MY139106A/en unknown
- 2004-07-16 TW TW093121231A patent/TWI337870B/zh not_active IP Right Cessation
- 2004-07-19 US US10/894,333 patent/US20050025792A1/en not_active Abandoned
-
2006
- 2006-01-12 IL IL173112A patent/IL173112A0/en not_active IP Right Cessation
- 2006-09-21 HK HK06110507.9A patent/HK1089951A1/xx not_active IP Right Cessation
-
2008
- 2008-09-26 US US12/238,490 patent/US20090069411A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2004262495B2 (en) | 2011-02-03 |
BRPI0412740A (pt) | 2006-09-26 |
KR20060052834A (ko) | 2006-05-19 |
CN100566758C (zh) | 2009-12-09 |
US20090069411A1 (en) | 2009-03-12 |
CN1822859A (zh) | 2006-08-23 |
MY139106A (en) | 2009-08-28 |
JP2009513557A (ja) | 2009-04-02 |
MXPA06000633A (es) | 2006-04-19 |
TWI337870B (en) | 2011-03-01 |
TW200518772A (en) | 2005-06-16 |
EP1648517B1 (en) | 2008-08-20 |
ATE405293T1 (de) | 2008-09-15 |
US20050025792A1 (en) | 2005-02-03 |
HK1089951A1 (en) | 2006-12-15 |
WO2005014048A1 (en) | 2005-02-17 |
AU2004262495A1 (en) | 2005-02-17 |
CA2532566A1 (en) | 2005-02-17 |
EP1498143A1 (en) | 2005-01-19 |
EP1648517A1 (en) | 2006-04-26 |
IL173112A0 (en) | 2006-06-11 |
DE602004015994D1 (de) | 2008-10-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR045911A1 (es) | Formulaciones auto-emulsionables y formulaciones auto-microemulsionables para la administracion oral de taxoides | |
UY30099A1 (es) | Una composicion solida de taxano liofilizado, un procedimiento para preparar dicha composicion solida, una formulacion farmacéutica y un conjunto (kit) para la preparacion de una formulacion inyectable de taxano | |
ATE270544T1 (de) | Halbfeste arzneizubereitung enthaltend isotretinoin | |
CO5580835A2 (es) | Nuevas formulaciones analogas de ciclosporina | |
BRPI0509053A (pt) | composição farmacêutica anidra e uso de um agente siliconado e de uma composição | |
ES2721148T3 (es) | Composiciones farmacéuticas de paclitaxel, análogos de paclitaxel o conjugados de paclitaxel y métodos relacionados de preparación y uso | |
AR037951A1 (es) | Composiciones farmaceuticas de derivados de taxano oralmente activos que tienen biodisponibilidad mejorada | |
ES2163926T3 (es) | Nanoemulsion a base de eteres grasos etoxilados o esteres grasos etoxilados, y sus utilizaciones en los ambitos cosmeticos, dermatologicos y/u oftalmologicos. | |
CL2007003447A1 (es) | Composicion lubricante que comprende un aceite base, fosfato tricalcico en concentraciones de 2 a 68% en peso relativo a la composicion total y un agente tensioactivo; y uso de dicah composicion. | |
BRPI0717219B8 (pt) | composição imunogênica, e, uso de uma composição imunogênica | |
AR055115A1 (es) | Composiciones antitrnspirantes | |
PT977562E (pt) | Metodos e composicoes para administracao de taxanos | |
ES2165725T3 (es) | Nanoemulsion a base de esteres grasos de acido fosforico, y sus utilizaciones en los ambitos cosmetico, dermatologico, farmaceutico y/u oftalmologico. | |
CO5390073A1 (es) | Forma de dosificacion oral solida de simeticona | |
ECSP078023A (es) | Ingrediente farmacéutico activo en base a canabinoide | |
FR2718963B1 (fr) | Nouvelle composition pharmaceutique à base de taxoïdes. | |
CY1109507T1 (el) | Φαρμακευτικη συνθεση η οποια περιλαμβανει ενα ελαστομερες οργανοπολυσιλοξανιο και μια διαλυτοποιημενη δραστικη ουσια | |
AR037687A1 (es) | Composiciones farmaceuticas a base de derivados de azetidina | |
CO5540294A2 (es) | Una combinacion de un derivado de rapamicina y un agente alquilante seleccionado de ciclofosfamida y carmustina y composiciones que las contienen | |
GT199900129A (es) | Formulaciones liquidas de pirimetanilo y metodos para su preparacion. | |
CL2004001843A1 (es) | Combinacion de (a) al menos un derivado 2,5-dihidrobencenosulfonico, como el dobeilato calcico, etamsilato y persilato, y (b) al menos un modulador de los canales de potasio, composicion farmaceutica que la contiene y uso como medicamento en profilax | |
AR045996A1 (es) | Formulaciones semi-solidas para la administracion oral de taxoides | |
BRPI0411954A (pt) | nanopartìculas de derivados poli-oxietilenados e respectivo método de preparação | |
BRPI0518088A (pt) | composição oleosa comestìvel e seu uso | |
HRPK20030766B3 (en) | Combination of a taxane and cyclin-dependent kinase inhibitor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |